AMANDA ADCOCK: Open Payments
NPI 1730579889 · DECATUR, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,717 in 148 payments from 25 companies in 2025. Trend: 2023 $1,534 · 2024 $828 · 2025 $2,717
Food & beverage: $2,717
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $375 |
| UCB, Inc. | 40 | $343 |
| Eisai Inc. | 9 | $241 |
| Neurocrine BioSciences, Inc. | 8 | $191 |
| Biogen, Inc. | 7 | $181 |
| Axsome Therapeutics, Inc. | 9 | $160 |
| Alexion Pharmaceuticals, Inc. | 5 | $138 |
| SK Life Science, Inc. | 6 | $128 |
| Neurelis, Inc. | 7 | $124 |
| Merz Pharmaceuticals, LLC | 4 | $113 |
Products named: LEQEMBI, BOTOX, Briviact, INGREZZA, Symbravo, Fintepla, ULTOMIRIS, VALTOCO.
Industry payments across AL — which companies pay providers there.
